These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14748754)

  • 1. Lamotrigine kidney distribution in male rats following a single intraperitoneal dose.
    Castel-Branco MM; Falcão AC; Figueiredo IV; Macedo TR; Caramona MM
    Fundam Clin Pharmacol; 2004 Feb; 18(1):51-5. PubMed ID: 14748754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of administration vehicles and drug formulations on the pharmacokinetic profile of lamotrigine in rats.
    Castel-Branco MM; Figueiredo IV; Falcão AC; Macedo TR; Caramona MM
    Fundam Clin Pharmacol; 2002 Oct; 16(5):331-6. PubMed ID: 12602457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of various antiepileptic drugs on plasma levels of lamotrigine, a novel antiepileptic, in rats.
    Yamashita S; Furuno K; Moriyama M; Kawasaki H; Gomita Y
    Pharmacology; 1997 Jun; 54(6):319-27. PubMed ID: 9286816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pregnancy on the pharmacokinetics of lamotrigine in dogs.
    Matar KM; Nicholls PJ; Tekle A; Bawazir SA; Al-Hassan MI
    Epilepsia; 1999 Oct; 40(10):1353-6. PubMed ID: 10528929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of Garcinia cambogia extract on the pharmacokinetics of lamotrigine given as a single-dose in Wistar rats.
    Ventura S; Rodrigues M; Falcão A; Alves G
    Food Chem Toxicol; 2019 Jun; 128():61-67. PubMed ID: 30940594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response.
    Bartoli A; Guerrini R; Belmonte A; Alessandrì MG; Gatti G; Perucca E
    Ther Drug Monit; 1997 Jun; 19(3):252-60. PubMed ID: 9200763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients.
    Doose DR; Brodie MJ; Wilson EA; Chadwick D; Oxbury J; Berry DJ; Schwabe S; Bialer M
    Epilepsia; 2003 Jul; 44(7):917-22. PubMed ID: 12823574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects.
    Hermann R; Knebel NG; Niebch G; Richards L; Borlak J; Locher M
    Eur J Clin Pharmacol; 2003 Apr; 58(12):795-802. PubMed ID: 12698305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine in pregnancy and lactation: a case report.
    Tomson T; Ohman I; Vitols S
    Epilepsia; 1997 Sep; 38(9):1039-41. PubMed ID: 9579945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium valproate acutely inhibits lamotrigine metabolism.
    Yuen AW; Land G; Weatherley BC; Peck AW
    Br J Clin Pharmacol; 1992 May; 33(5):511-3. PubMed ID: 1524964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.
    Ohman I; Vitols S; Tomson T
    Epilepsia; 2000 Jun; 41(6):709-13. PubMed ID: 10840403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and pharmacokinetics of oral loading with lamotrigine in epilepsy monitoring units.
    Lardizabal DV; Morris HH; Hovinga CA; Del Mar Carreño M
    Epilepsia; 2003 Apr; 44(4):536-9. PubMed ID: 12681002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of lamotrigine (Lamictal) in plasma and saliva.
    Trnavska Z; Krejcova H; Tkaczykovam ; Salcmanova Z; Elis J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():211-5. PubMed ID: 1820881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats.
    Castel-Branco MM; Falcão AC; Figueiredo IV; Caramona MM
    Fundam Clin Pharmacol; 2005 Dec; 19(6):669-75. PubMed ID: 16313279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.
    He DK; Wang L; Qin J; Zhang S; Lu W; Li L; Zhang JM; Bao WQ; Song XQ; Liu HT
    Acta Pharmacol Sin; 2012 Nov; 33(11):1417-23. PubMed ID: 23103620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
    Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
    Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
    Gulcebi MI; Ozkaynakcı A; Goren MZ; Aker RG; Ozkara C; Onat FY
    Epilepsy Res; 2011 Jun; 95(1-2):1-8. PubMed ID: 21601426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal absorption of lamotrigine compressed tablets.
    Birnbaum AK; Kriel RL; Burkhardt RT; Remmel RP
    Epilepsia; 2000 Jul; 41(7):850-3. PubMed ID: 10897156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva and serum concentration of lamotrigine in patients with epilepsy.
    Tsiropoulos I; Kristensen O; Klitgaard NA
    Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and dosage implications.
    Armijo JA; Bravo J; Cuadrado A; Herranz JL
    Ther Drug Monit; 1999 Apr; 21(2):182-90. PubMed ID: 10217338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.